by Lise Jamieson, Leigh F. Johnson, Jeffrey W. Imai-Eaton, Hasina Subedar, Linda-Gail Bekker, Gesine Meyer-Rath Background South Africa accounts for 20% of global HIV infections. Six-monthly injectable lenacapavir (LEN) for HIV pre-exposure prophylaxis (PrEP) has superior efficacy to oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC), and similar efficacy to 2-monthly injectable…
Scaling up PEN‑Plus: expanding life-saving care for severe noncommunicable diseases in Africa mtabi@who.int Tue, 21/07/2026 - 14:05 Severe noncommunicable diseases (NCDs) remain a significant yet…
Ten years ago, a pioneering AI scientist predicted that computers would replace human experts as readers of medical images. It hasn’t exactly worked out that way.
